A/Prof Catherine Satzke
A/Prof Catherine Satzke
Details
Role
Group Leader/Principal Research Fellow
Research area
Infection, Immunity and Global Health
Contact
Available for student supervision
A/Prof Satzke obtained her PhD in molecular microbiology from The University of Melbourne in 2007. She then established a microbiological research laboratory at the Murdoch Childrens Research Institute within the Pneumococcal Research Group led by Prof Kim Mulholland.
A/Prof Satzke led a project funded by the Bill and Melinda Gates Foundation which involved over 20 international collaborators. She has since attracted further funds to establish two serotype reference centres, facilitating vaccine impact studies in Asia. She led the update of World Health Organization (WHO) standards for pneumococcal carriage studies and made important contributions to studies in Fiji, leading to vaccination introduction.
A/Prof Satzke has been an investigator on grants totalling $39.7 million, notably $3.1 million as co-principal investigator on a Bill and Melinda Gates Foundation grant. A/Prof Satzke received the inaugural veski inspiring women fellowship (2015-), the prestigious international Robert Austrian Research award (2012), has been an invited speaker at six international conferences and co-organised a WHO meeting.
A/Prof Satzke has published in journals including PLOS Medicine, Lancet, Vaccine and PLOS Pathogens. She currently supervises two post-doctoral researchers, five research assistants, one administrator, two PhD and one Honours student, and regularly hosts Masters students. A/Prof Satzke was named Murdoch Childrens' supervisor of the year in 2013.
A/Prof Satzke led a project funded by the Bill and Melinda Gates Foundation which involved over 20 international collaborators. She has since attracted further funds to establish two serotype reference centres, facilitating vaccine impact studies in Asia. She led the update of World Health Organization (WHO) standards for pneumococcal carriage studies and made important contributions to studies in Fiji, leading to vaccination introduction.
A/Prof Satzke has been an investigator on grants totalling $39.7 million, notably $3.1 million as co-principal investigator on a Bill and Melinda Gates Foundation grant. A/Prof Satzke received the inaugural veski inspiring women fellowship (2015-), the prestigious international Robert Austrian Research award (2012), has been an invited speaker at six international conferences and co-organised a WHO meeting.
A/Prof Satzke has published in journals including PLOS Medicine, Lancet, Vaccine and PLOS Pathogens. She currently supervises two post-doctoral researchers, five research assistants, one administrator, two PhD and one Honours student, and regularly hosts Masters students. A/Prof Satzke was named Murdoch Childrens' supervisor of the year in 2013.
A/Prof Satzke obtained her PhD in molecular microbiology from The University of Melbourne in 2007. She then established a microbiological research laboratory at the Murdoch Childrens Research Institute within the Pneumococcal Research Group led by...
A/Prof Satzke obtained her PhD in molecular microbiology from The University of Melbourne in 2007. She then established a microbiological research laboratory at the Murdoch Childrens Research Institute within the Pneumococcal Research Group led by Prof Kim Mulholland.
A/Prof Satzke led a project funded by the Bill and Melinda Gates Foundation which involved over 20 international collaborators. She has since attracted further funds to establish two serotype reference centres, facilitating vaccine impact studies in Asia. She led the update of World Health Organization (WHO) standards for pneumococcal carriage studies and made important contributions to studies in Fiji, leading to vaccination introduction.
A/Prof Satzke has been an investigator on grants totalling $39.7 million, notably $3.1 million as co-principal investigator on a Bill and Melinda Gates Foundation grant. A/Prof Satzke received the inaugural veski inspiring women fellowship (2015-), the prestigious international Robert Austrian Research award (2012), has been an invited speaker at six international conferences and co-organised a WHO meeting.
A/Prof Satzke has published in journals including PLOS Medicine, Lancet, Vaccine and PLOS Pathogens. She currently supervises two post-doctoral researchers, five research assistants, one administrator, two PhD and one Honours student, and regularly hosts Masters students. A/Prof Satzke was named Murdoch Childrens' supervisor of the year in 2013.
A/Prof Satzke led a project funded by the Bill and Melinda Gates Foundation which involved over 20 international collaborators. She has since attracted further funds to establish two serotype reference centres, facilitating vaccine impact studies in Asia. She led the update of World Health Organization (WHO) standards for pneumococcal carriage studies and made important contributions to studies in Fiji, leading to vaccination introduction.
A/Prof Satzke has been an investigator on grants totalling $39.7 million, notably $3.1 million as co-principal investigator on a Bill and Melinda Gates Foundation grant. A/Prof Satzke received the inaugural veski inspiring women fellowship (2015-), the prestigious international Robert Austrian Research award (2012), has been an invited speaker at six international conferences and co-organised a WHO meeting.
A/Prof Satzke has published in journals including PLOS Medicine, Lancet, Vaccine and PLOS Pathogens. She currently supervises two post-doctoral researchers, five research assistants, one administrator, two PhD and one Honours student, and regularly hosts Masters students. A/Prof Satzke was named Murdoch Childrens' supervisor of the year in 2013.
Top Publications
- Licciardi, PV, Chokephaibulkit, K, Satzke, C. Pneumococcal serosurveillance: one piece of the puzzle. The Lancet Infectious Diseases 23(11) : 1212 -1214 2023 view publication
- Temple, B, Tran, HP, Dai, VTT, Smith-Vaughan, H, Group, TV-IC, Balloch, A, Beissbarth, J, Bright, K, Higgins, RA, Hinds, J, et al. Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam: a parallel, single-blind, randomised controlled trial. The Lancet Infectious Diseases 23(8) : 933 -944 2023 view publication
- Jagne, I, von Mollendorf, C, Wee-Hee, A, Ortika, B, Satzke, C, Russell, FM. A systematic review of pneumococcal conjugate vaccine impact on pneumococcal nasopharyngeal colonisation density in children under 5 years of age. Vaccine 41(19) : 3028 -3037 2023 view publication
- Smith-Vaughan, H, Temple, B, Dai, VTT, Hoan, PT, Thuy, HNL, Phan, TV, Bright, K, Toan, NT, Uyen, DY, Nguyen, CD, et al. Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trial. The Lancet Regional Health - Western Pacific 32: 100651 2023 view publication
- Nation, ML, Manna, S, Tran, HP, Nguyen, CD, Vy, LTT, Uyen, DY, Phuong, TL, Dai, VTT, Ortika, BD, Wee-Hee, AC, et al. Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam. Microbiology Spectrum 11(1) : e03615 -e03622 2023 view publication
Page 1 of 23
Career information
Share //
